Company Filing History:
Years Active: 2014
Title: Biography of Inventor Troy M Harmon
Introduction: Troy M Harmon is an accomplished inventor based in Lansdale, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms.
Latest Patents: Troy holds a patent for "Orally disintegrating tablets of atomoxetine." This invention involves a coated multi-particulate pharmaceutical dosage form designed to deliver atomoxetine, a selective norepinephrine reuptake inhibitor used in the treatment of ADHD. The orally disintegrating tablet (ODT) is engineered to maintain a therapeutically effective amount of atomoxetine in the plasma, featuring a rapid release profile after a pre-designed lag time of 0 to 6 hours following oral administration.
Career Highlights: Troy is currently associated with Aptalis Pharmatech, Inc., where he applies his expertise in pharmaceutical formulation and development. His work focuses on creating effective and patient-friendly medication delivery systems.
Collaborations: Throughout his career, Troy has collaborated with notable professionals in the industry, including Gopi M Venkatesh and John Taylor. These collaborations have contributed to the advancement of innovative pharmaceutical solutions.
Conclusion: Troy M Harmon is a dedicated inventor whose work in the pharmaceutical field has the potential to improve the lives of individuals with ADHD. His innovative approach to drug delivery continues to influence the industry positively.